Is Medicenna Therapeutics Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: MDNA) stock is to Buy MDNA stock.
Out of 1 analyst, 0 (0%) are recommending MDNA as a Strong Buy, 1 (100%) are recommending MDNA as a Buy, 0 (0%) are recommending MDNA as a Hold, 0 (0%) are recommending MDNA as a Sell, and 0 (0%) are recommending MDNA as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year MDNA price target, the average MDNA price target is $2.50, with the highest MDNA stock price forecast at $2.50 and the lowest MDNA stock price forecast at $2.50.
The Wall Street analyst predicted that Medicenna Therapeutics's share price could reach $2.50 by Feb 8, 2024. The average Medicenna Therapeutics stock price prediction forecasts a potential upside of 364.68% from the current MDNA share price of $0.54.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.